Cathechol-O-methyltransferase Val158Met polymorphism is associated with nocebo effects, but not with methotrexate intolerance in patients with juvenile idiopathic arthritis.

Scandinavian journal of rheumatology

PubMedID: 28105896

Hügle B, Scheuern A, Dollinger S, Fischer N, Haas JP. Cathechol-O-methyltransferase Val158Met polymorphism is associated with nocebo effects, but not with methotrexate intolerance in patients with juvenile idiopathic arthritis. Scand J Rheumatol. 2017;1-2.
An abstract is not available. Please access the article through the links below.